How effective is a community based pulmonary rehabilitation programme for patients with mild to moderate chronic obstructive pulmonary disease?

How effective is a COMmunity based Pulmonary rehabilitation progrAmme for patients with mild to moderate Chronic ObsTructive Pulmonary Disease? (COMPACT study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN21489342

Enrollment

Registered

2017-02-17

Start date

2017-01-10

Completion date

Unknown

Last updated

2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease Respiratory Chronic Obstructive Pulmonary Disease

Interventions

30 people who undertake the community based pulmonary rehabilitation programme (intervention group) within a 6 month timescale and 30 people who sign up for a community based pulmonary rehabilitation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases: 1. Above 35 years old 2. Male and female 3. Clinical Diagnosis of COPD 4. MRC dyspnoea score of 1-2 5. Self enrolled onto and able to complete a community based pulmonary rehabilitation programme within 6 month time period (Jan - June 2017) Control: 1. Above 35 years old 2. Male and Female 3. Clinical Diagnosis of COPD 4. MRC dyspnoea score of 1-2 5. Self enrolled onto but not able to start a community based pulmonary rehabilitation programme within the 6 month time period (Jan - June 2017)

Exclusion criteria

Exclusion criteria: 1. Those unwilling or unable to provide written consent. 2. Resident in an area not covered by the Hywel Dda University Health Board EPP team. 3. Those unable or unwilling to attend at least 5 of the planned 7 ‘COPD +’ sessions (Group A only). 4. MRC dyspnoea score 3-5

Design outcomes

Primary

Measure	Time frame
COPD self management is assessed through review of the primary and secondary care databases by the researcher to assess the number of health care professional face to face contacts, telephone contacts and admissions to hospital during the 6 months pre / post attending a community based pulmonary rehabilitation programme.	—

Secondary

Measure	Time frame
1. Participants and Control group: Exercise tolerance of the Intervention group compared to the Controls is assessed using data observed during incremental walk tests at Day 1, Week 9 and 6 Months 2. Participants and Control group: General Health of the Intervention Group compared to the Control group is assessed using the validated, self completed, EQ5D questionnaire at Day 1, Week 9 and 6 Months 3. Participants and Control group: COPD symptom control of the Intervention Group compared to the Control group is assessed using the validated, self completed, COPD Assessment Test (CAT) questionnaire at Day 1, Week 9 and 6 Months 4. For participants only: The cost effectiveness of the community based pulmonary rehabilitation programme will be assessed using statistical analysis via SPSS version 22.2 (Chicago, Illinois) based upon changes in EQ5D, healthcare contacts and deaths within the 12 month research period (6 months pre course and 6 months post course) 5. For participants only, completion rates for the community based pulmonary rehabilitation programme and reasons for non completion will be assessed using the attendance register for the participants course at the 9 week assessment 6. For participants only, reasons for non completion of the community based pulmonary rehabilitation programme will be assessed by telephone interview with the participant by the research team at the 9 week assessment	—

Measure

Time frame

1. Participants and Control group: Exercise tolerance of the Intervention group compared to the Controls is assessed using data observed during incremental walk tests at Day 1, Week 9 and 6 Months 2. Participants and Control group: General Health of the Intervention Group compared to the Control group is assessed using the validated, self completed, EQ5D questionnaire at Day 1, Week 9 and 6 Months 3. Participants and Control group: COPD symptom control of the Intervention Group compared to the Control group is assessed using the validated, self completed, COPD Assessment Test (CAT) questionnaire at Day 1, Week 9 and 6 Months 4. For participants only: The cost effectiveness of the community based pulmonary rehabilitation programme will be assessed using statistical analysis via SPSS version 22.2 (Chicago, Illinois) based upon changes in EQ5D, healthcare contacts and deaths within the 12 month research period (6 months pre course and 6 months post course) 5. For participants only, completion rates for the community based pulmonary rehabilitation programme and reasons for non completion will be assessed using the attendance register for the participants course at the 9 week assessment 6. For participants only, reasons for non completion of the community based pulmonary rehabilitation programme will be assessed by telephone interview with the participant by the research team at the 9 week assessment

—

Countries

United Kingdom

Contacts

Public ContactSarah Hicks

sarah.hicks@wales.nhs.uk+44 1267 239662

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026